Allgens Medical Technology (688613.SH): BioVeda intends to reduce its shareholding by no more than 1%.

Allgens Medical Technology (688613.SH) announced that the company recently received a notice from BioVeda regarding their plan to reduce their shareholding. Due to their own financial arrangements, BioVeda will reduce their holdings in Allgens Medical Technology through block trades and centralized bidding based on market conditions. BioVeda plans to reduce their stake in Allgens Medical Technology by no more than 1,355,515 shares, representing 1% of the total shares of Allgens Medical Technology.